Kimyrsa Interactions
There are 453 drugs known to interact with Kimyrsa (oritavancin), along with 4 disease interactions. Of the total drug interactions, 25 are major, 410 are moderate, and 18 are minor.
- View all 453 medications that may interact with Kimyrsa
- View Kimyrsa disease interactions (4)
Most frequently checked interactions
View interaction reports for Kimyrsa (oritavancin) and the medicines listed below.
- Aimovig (erenumab)
- albuterol
- amoxicillin
- benzonatate
- calcium / vitamin d
- cetirizine
- ciprofloxacin
- clarithromycin
- diltiazem
- doxycycline
- Dulcolax (bisacodyl)
- Dulcolax Stool Softener (docusate)
- Emgality (galcanezumab)
- Evenity (romosozumab)
- Fioricet (acetaminophen / butalbital / caffeine)
- Flonase (fluticasone nasal)
- Florastor (saccharomyces boulardii lyo)
- folic acid
- Fosamax (alendronate)
- Linzess (linaclotide)
- lubiprostone
- meloxicam
- methocarbamol
- MiraLAX (polyethylene glycol 3350)
- mirtazapine
- Mucinex DM (dextromethorphan / guaifenesin)
- mupirocin topical
- nortriptyline
- Omega-3 Fish Oil (omega-3 polyunsaturated fatty acids)
- Orencia (abatacept)
Kimyrsa disease interactions
There are 4 disease interactions with Kimyrsa (oritavancin) which include:
Report options
QR code containing a link to this page
More about Kimyrsa (oritavancin)
- Kimyrsa consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: glycopeptide antibiotics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
